By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Calcineurin inhibitor > Tacrolimus

Tacrolimus

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|625 words

Tacrolimus: A Powerful Immunosuppressive Medication

What is Tacrolimus?

Tacrolimus is a potent immunosuppressive medication that belongs to a class of drugs called calcineurin inhibitors. It is primarily used to prevent organ rejection in patients who have received kidney, liver, or heart transplants. This medication works by suppressing the immune system to prevent it from attacking transplanted organs as foreign tissue.

Uses

Tacrolimus has several important medical applications:

  • Organ transplant rejection prevention: The primary use is preventing rejection in kidney, liver, and heart transplant recipients by suppressing immune system activity
  • Atopic dermatitis: Topical tacrolimus ointment is used to treat moderate to severe eczema when other treatments haven’t been effective
  • Autoimmune conditions: Sometimes prescribed off-label for certain autoimmune disorders like inflammatory bowel disease or rheumatoid arthritis
  • Graft-versus-host disease: Used to treat this serious complication that can occur after bone marrow or stem cell transplants
  • Severe psoriasis: In some cases, it may be prescribed for difficult-to-treat psoriasis when other therapies have failed

How it works

Tacrolimus works by blocking calcineurin, an enzyme that plays a crucial role in activating T-lymphocytes (a type of white blood cell). When calcineurin is inhibited, T-cells cannot properly activate and multiply, which reduces the immune system’s ability to mount an attack against transplanted organs. This selective immunosuppression helps maintain transplanted organs while still preserving some immune function to fight infections.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Kidney problems and elevated creatinine levels
  • High blood pressure
  • Tremor or shaking hands
  • Headache
  • Nausea and diarrhea
  • Increased risk of infections
  • Elevated blood sugar levels
  • Insomnia or sleep disturbances

Serious side effects to watch for:

  • Increased risk of certain cancers, particularly skin cancer and lymphoma
  • Severe kidney damage or failure
  • Serious infections due to immunosuppression
  • Nervous system toxicity including seizures or confusion
  • Heart problems including enlarged heart muscle

Warnings and precautions

  • Pregnancy considerations: Tacrolimus is classified as pregnancy category C, meaning it should only be used when benefits outweigh potential risks to the fetus
  • Kidney function monitoring: Regular blood tests are essential as tacrolimus can cause significant kidney damage, especially at higher doses
  • Infection risk: Patients must be monitored closely for signs of infection due to the immunosuppressive effects
  • Cancer screening: Long-term use increases cancer risk, requiring regular skin examinations and cancer screening
  • Liver function: Patients with liver problems may need dose adjustments as tacrolimus is metabolized by the liver

Interactions

Tacrolimus has numerous significant drug interactions:

  • Ketoconazole and other antifungal medications: Can increase tacrolimus levels dangerously by inhibiting its metabolism
  • Rifampin: Reduces tacrolimus effectiveness by increasing its breakdown in the liver
  • Cyclosporine: Should not be used together due to increased risk of kidney toxicity
  • Live vaccines: Should be avoided due to immunosuppression increasing infection risk
  • Grapefruit juice: Can increase tacrolimus blood levels and should be avoided
  • St. John’s wort: May decrease tacrolimus levels by increasing its metabolism
  • ACE inhibitors and ARBs: May increase risk of kidney problems when combined
  • NSAIDs: Can worsen kidney function when used with tacrolimus

Check interactions with the GMJ Interaction Checker

Dosage

Tacrolimus dosing is highly individualized and must be carefully monitored through blood level testing. For oral tacrolimus in transplant patients, initial doses typically range from 0.1 to 0.2 mg/kg daily, divided into two doses taken 12 hours apart. For topical tacrolimus ointment used for eczema, concentrations of 0.03% or 0.1% are applied twice daily to affected areas. Blood levels are regularly monitored to ensure therapeutic levels while avoiding toxicity. Dosage adjustments are frequently necessary based on blood levels, kidney function, and individual patient response. Always follow your healthcare provider’s specific dosing instructions, as tacrolimus requires careful medical supervision.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Tacrolimus." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/tacrolimus/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Chronic graft-versus-host disease: diagnosis and management emerge as priority in transplant care Obinutuzumab Outperforms Tacrolimus for Primary Membranous Nephropathy
In the news
  • Chronic graft-versus-host disease: diagnosis and management emerge as priority in transplant care · Jul 10, 2026
  • Obinutuzumab Outperforms Tacrolimus for Primary Membranous Nephropathy · Jul 9, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
U-shaped sleep curve reveals distinct aging patterns: short sleep drives aging, long sleep signals underlying disease

A Nature study of 500,000 UK adults reveals a U-shaped relationship between…

How Brew Time Transforms Tea Chemistry: What Science Reveals About Steeping Duration

Research mapping tea extraction kinetics reveals that steeping duration fundamentally alters the…

The Case for ‘Health Care’: Why Language Precision Matters in Medical Journalism

STAT News's recent reader poll found that approximately 60% of respondents prefer…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Ciclosporin

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up